ADA anticorps (AA 287-314)
Aperçu rapide pour ADA anticorps (AA 287-314) (ABIN3029872)
Antigène
Voir toutes ADA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 287-314
-
Purification
- Purified
-
Immunogène
- A portion of amino acids 287-314 from the human protein was used as the immunogen for this ADA antibody.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Titration of the ADA antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:100-1:250
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the ADA antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- ADA (Adenosine Deaminase (ADA))
-
Autre désignation
- ADA
-
Sujet
- This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins, whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.
-
UniProt
- P00813
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Ribonucleoside Biosynthetic Process
Antigène
-